Directors' dealings: BB Biotech AG: Director's Dealings announcement according to §15a WpHG (the German Securities Trading Act)

BB Biotech AG / Directors' dealings: Director's Dealings announcement
according to §15a WpHG (the German Securities Trading Act)

Director's Dealings announcement according to §15a WpHG (the German
Securities Trading Act) processed and transmitted by Hugin. The
issuer is solely responsible for the content of this announcement.

----------------------------------------------------------------------
--------------

--------------------------------------------------------------------------------
Details of the person subject to the disclosure requirement
--------------------------------------------------------------------------------

Clive Meanwell

Person with executive functions
- Member of administrative or supervisory body

--------------------------------------------------------------------------------
Details of the transaction
--------------------------------------------------------------------------------

Type of transaction...........: Sell
Date..........................: 31.10.2008
Place (stock exchange)........: SIX Zürich
Price.........................: 68,00
Currency......................: CHF
Quantity......................: 3.500
Business volume...............: 237333,60

It is a correction of the release published on 03.02.2009.

BB Biotech AG
Vordergasse 3
Schaffhausen CH-8200
Switzerland

Index:
- HDAX
- MIDCAP
- Prime All Share
- TECH All Share
- TecDAX
Listed:
- Regulierter Markt in Frankfurter Wertpapierbörse

--- End of Message ---

BB Biotech AG
Vordergasse 3 Schaffhausen Switzerland

WKN: 888509;
ISIN: CH0001441580 ; Index: Prime All Share, MIDCAP, TECH All Share,
TecDAX, HDAX;
Listed: Regulierter Markt in Frankfurter Wertpapierbörse;
Copyright © Hugin AS 2009. All rights reserved.